"Inflammation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function.
| Descriptor ID |
D007249
|
| MeSH Number(s) |
C23.550.470
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Inflammation".
Below are MeSH descriptors whose meaning is more specific than "Inflammation".
This graph shows the total number of publications written about "Inflammation" by people in this website by year, and whether "Inflammation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1998 | 0 | 1 | 1 |
| 2000 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 4 | 5 |
| 2005 | 0 | 3 | 3 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 4 | 4 |
| 2008 | 4 | 6 | 10 |
| 2009 | 4 | 4 | 8 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 6 | 9 |
| 2012 | 4 | 4 | 8 |
| 2013 | 1 | 8 | 9 |
| 2014 | 2 | 2 | 4 |
| 2015 | 2 | 6 | 8 |
| 2016 | 5 | 4 | 9 |
| 2017 | 5 | 3 | 8 |
| 2018 | 4 | 8 | 12 |
| 2019 | 2 | 7 | 9 |
| 2020 | 3 | 8 | 11 |
| 2021 | 3 | 4 | 7 |
| 2022 | 0 | 10 | 10 |
| 2023 | 0 | 11 | 11 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Inflammation" by people in Profiles.
-
Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints. Nat Commun. 2024 Apr 15; 15(1):3225.
-
Phenylpropanoid-enriched broccoli seedling extract can reduce inflammatory markers and pain behavior. J Transl Med. 2023 Dec 19; 21(1):922.
-
Serotonin reduction in post-acute sequelae of viral infection. Cell. 2023 10 26; 186(22):4851-4867.e20.
-
A deeper dive into the REPRIEVE trial and the potential role of inflammation in residual risk. J Clin Lipidol. 2023 Sep-Oct; 17(5):563-566.
-
Early antibody treatment, inflammation, and risk of post-COVID conditions. mBio. 2023 Oct 31; 14(5):e0061823.
-
Iatrogenic air embolism: pathoanatomy, thromboinflammation, endotheliopathy, and therapies. Front Immunol. 2023; 14:1230049.
-
Tau fibrils induce glial inflammation and neuropathology via TLR2 in Alzheimer's disease-related mouse models. J Clin Invest. 2023 09 15; 133(18).
-
Multi-omics approach to socioeconomic disparity in metabolic syndrome reveals roles of diet and microbiome. Proteomics. 2023 10; 23(19):e2300023.
-
Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection. Clin Infect Dis. 2023 07 26; 77(2):272-279.
-
T cell activation is insufficient to drive SIV disease progression. JCI Insight. 2023 07 24; 8(14).